Richard Payerchin is editor of Medical Economics.
Value-based payment: Sources and a summary
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
Value-based payment: An introduction to a study
Health care adds 53K jobs in November as unemployment inches up
Monthly report shows gains for hospitals, home health care services.
CVD, drugs, guns, crashes – hazards hinder life expectancy care for Americans
How is life different across the pond? UK babies can expect to live longer than newborn Americans.
Tirzepatide tops semaglutide for patient weight loss, study finds
The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.
GLP-1 RA drugs and primary care: What do physicians need to know?
Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.
Health care for older adults around the world: A slideshow
The Commonwealth Fund compares United States with other developed nations.
GLP-1 RA antiobesity medications: Predictions for the future
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
‘People who’ve gone to medical school are not practicing medicine’
Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.
Are physicians embracing work-life balance over ‘workaholic culture?’
‘Old guys are taking ER call’ as younger docs ponder medicine as a calling, or just a job.
GLP-1 RA antiobesity medications: Long-term safety
Medical organizations call for congressional action as calendar approaches end of 2024
The clock is ticking for lawmakers to approve policies that could affect U.S. health care.
GLP-1 RA antiobesity medications: Learning about side effects, and managing them
GLP-1 RA antiobesity medications: Lifestyle changes needed too
GLP-1 RA antiobesity medications: Talking about cost
More workplace control leads to less burnout for physicians in health systems, study finds
Institutional leaders want to standardize practices, but flexibility may be a key to keeping doctors.
GLP-1 RA antiobesity medications: Patients’ No. 1 question
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Proposals would require more public data on prior authorization processes and whether those advance health equity.
Medicare announces 2026 plan to cover antiobesity medications
Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.
GLP-1 RA antiobesity medications: a new panacea?
GLP-1 RA antiobesity medications: an introduction
New HHS leader could overhaul Medicare physician reimbursement: reports
News reports state RFK Jr. could take aim at codes recommended by the American Medical Association.
Study finds patients paying for insurance still pile on medical debt, or skip care to avoid it
Commonwealth Fund examines underinsureds, now more than 20% of the people with health insurance around the country.
Medicaid ‘at an unprecedented crossroads … progress is at risk,’ program leader says
CMS Medicaid chief foreshadows potential policy changes coming when President-elect Trump moves into the White House.
CMS chief: ‘It is the greatest honor and privilege to serve in this role’
Brooks-LaSure describes achievements in her final national leadership call.
Health insurance is at risk if premium tax credits are eliminated – a slideshow
How many people will be affected if Congress does not extend premium tax credits for ACA insurance?
Patient safety falling short: States where hospitals need improvement – a slideshow
Some states have few or no hospitals with ‘A’ grades for patient safety, according to the Leapfrog Group’s fall 2024 report card.
Hospitals improving patient safety grades, watchdog organization says
Leapfrog Group publishes fall 2024 marks for almost 3,000 facilities nationwide.
‘American health care is struggling’ – Assistant AG discusses morality, money and medicine
Antitrust chief says the nation is at an inflection point to restore competition or pay more money for less choice and more aggravation.
COVID-19 medical misinformation prompts much hand-wringing, but little hand-slapping for docs
Study finds spreading medical misinformation is low on the list of reasons for disciplinary actions against physicians in recent years.